Recombinant interferon-gamma (IFN-~,) in contact with human embryonic fibroblasts or with a great variety of cells from different animal species was phosphorylated in the presence of [7-32p]ATP and magnesium ions by a protein kinase released in the culture medium. Using SDS-polyacrylamide gel electrophoresis, we found that both the monomeric (17000 to 18000) and dimeric (34000 to 35000) molecular weight forms of IFN-~ became intensely radioactive. Serine, but not threonine or tyrosine, was phosphorylated. It is of interest that the kinase released from reputedly insensitive cells also phosphorylated IFN-% The process did not noticeably degrade the antiviral functions of the molecule nor did it affect, at least in a detectable manner, its anti-proliferative effect on WISH or Daudi cells. Furthermore, the antigenic structure and its capacity to react with monoclonal antibodies were also unaltered. It is presently not known which biological function is regulated by the phosphorylating process.
INTRODUCTION
Phosphorylation probably plays an important role in the transmission of intercellular signals and in the response of individual cells to hormones or other mediators. Protein kinase A is cAMP-and cGMP-dependent. Protein kinase C is activated by diacyl glycerol (an intermediate of the phosphatidylinositol metabolic cycle) in the presence of calcium ions and seems to be involved in the regulation of cell proliferation (Marx, 1984; Nishizuka, 1984) . Furthermore, a protein kinase has been reported which, when released from the outer cell membrane, can phosphorylate various substrates, such as phosvitin (K~ibler et al., 1983) , and for which presently no cellular function has been assigned.
We report here a new observation on the effect of such an apparently constitutively released protein kinase which, in the presence of [~-32p] ATP and magnesium ions, rapidly phosphorylates human recombinant interferon-gamma (IFN-~) (Scahill et al., 1983) in its monomeric and dimeric forms. The phosphorylation procedure does not result in a detectable inactivation of the molecule, as expressed in terms of antiviral protection and anti-proliferative effect. Binding to monoclonal antibodies is also not impaired, as estimated by Western blot analysis.
METHODS

Reagents.
Recombinant human IFN-y with a specific activity (sp. act.) of 3 x 107 units (U)/mg protein (780 ~tg/ml) or 7 x 107 U/mg protein (185 pg/ml), with a purity of >96~ and stabilized with human serum albumin, was provided by Biogen. Monoclonal antibody against human IFN-~, was employed at a dilution of 1/2000 as indicated by Biogen for use in Western blot analysis (sp. act. in solid phase radioimmunoassay 100000 to 300000) and affinity chromatography. IFN-fl [sp. act. 2 x 107 international units (IU)/mg protein] was purchased from Cytotech and Upsa Laboratories. Lymphoblastoid IFN-c~ (sp. act. 2 x 108 IU/mg protein) was provided by Hayashibara Biochemical Laboratories.
Mouse IFN (sp. act. 4 x 10 o IU/mg protein) was prepared in Ehrlich ascites tumour cells according to a previously described method (Dussaix et al., 1983 
ROBERT-GALLIOT AND OTHERS
Phosvitin and human serum albumin were from Sigma. Medium and serum were from Gibco. Activated CHSepharose 4B was purchased from Pharmacia.
The protein markers (electrophoresis calibration kit, Pharmacia) were: phosphorylase b (94000 tool. wt.), bovine albumin (67000), ovalbumin (43000), carbonic anhydrase (30000), trypsin inhibitor (20100) and ctlactalbumin (14400).
Horseradish peroxidase-conjugated anti-mouse IgG was prepared in rabbit (Miles Yeda, Rehovot, Israel The different IFNs were assayed by microtitration using the 50~ inhibition of vesicular stomatitis virusinduced cytopathic effect in three human cell lines, WISH, HeLa or F7000, for human IFN and in L cells for mouse IFN (Lebon et al., 1980) . The anti-proliferative properties were estimated using WISH or lymphoblastoid Daudi cells cultured in growth medium supplemented with 5 ~ calf serum (5 × 105 cells/ml). After 24, 48 and 72 h of incubation with IFN, the cells were treated with 10 ~tCi/ml [3H]thymidine (sp. act. 25 Ci/mmol; CEA). The incorporation of[3H]thymidine was measured in the acid-insoluble fractions at 24, 48 and 72 h. In parallel, the number of cells was counted in a haemocytometer.
Radioactire labelling. Adenosine 5'-[y-3-'P]triphosphate, triethylammonium salt, with asp. act. of 10 Ci/mmol (370 GBq/mmol), was purchased from Amersham. Labelling was carried out as described earlier (Kfibler et al., 1983 ) using a monolayer of l06 cells, washed twice with prewarmed assay mixture (70 mM-NaC1, 30 mM-Tri~ acetate, 5 mM-magnesium acetate, 5 mM-potassium phosphate, 0.5 mM-EDTA, 75 mM-glucose, pH 7.2). Phosphorylation of unbound IFN alter cell contact. After 15 min of incubation at 37°C, the assay mixtures, containing or not containing I FN or phosvitin, were removed from the monolayers of cells, centrifuged at 2500 g for 10 min. The supernatants (300 lal) were incubated in the presence of 0.5 ~tM-[y-32p]ATP for 15 min at 30 °C. Two aliquots of 100 ktl each were deposited on a Whatman 3MM filter and precipitated by washing three times with 10~o TCA at 4 °C. The radioactivity of the different preparations was determined in a beta scintillation counter (Intertechnique). Another aliquot (also 100 I_tl) was mixed with a sample buffer to stop the phosphorylation reaction and used for SDS-gel electrophoresis.
Labelling
Phosphorylation oflFN by kinases released by the cells. The cells were incubated with assay mixture for 15 min at 37 °C. The supernatants were collected by centrifugation at 2500g for 10 min. The IFNs were mixed 1/2 with the supernatants and incubated with [y-3-'P]ATP for 15 min at 30 °C. The radioactivity after TCA precipitation was counted as described above. SDS-gel electrophoresis was performed in the same manner as detailed below.
Analysis by SDS-polyacrylamide gel electrophoresis. SDS-PAGE was carried out according to a technique previously described (Laemmli, 1970) . All the aliquots were incubated with sample buffer (0.1 M-Tris-HCI pH 6.8, 2.5~ SDS, 10~o glycerol, 0-6 M-bromophenol blue, 1.54~ dithiothreitol), boiled for 3 min at 100 °C, and applied to a 15~o SDS polyacrylamide gel. The gels were then autoradiographed (Films Orwo HS 90).
Amino acid analysis. After electrophoresis on polyacrylamide gel, the samples were eluted and hydrolysed with 6 M-HCI at 110 °C for 2 h. The analysis of the amino acids was performed on a Liquimat 3 (Roche-Kontron), according to a previously described technique (Capony & Demaille, 1983) , using cation-exchange chromatography on columns containing DC6A sulphonated polystyrene resin (Durrum). The fractions were eluted with 1 ~t-trifluoroacetic acid. The order and height of the eluted peaks were estimated by their fluorescence using ophthaldialdehyde. Each fraction was tested for radioactivity. O-Phosphoserine, O-phosphothreonine and Ophosphotyrosine, employed as reference, were purchased from Sigma.
Electrophoretic transJer. After acrylamide gel (12.5~) electrophoresis, the proteins were blotted to a nitrocellulose filter, using a Trans-Blot cell apparatus (Bio-Rad) (40 V, 4 h) in Tris buffer pH 8.5 (10 mM-Tris-HCl, 150 mM-glycine, 20~o methanol). The filter was incubated with monoclonal antibody (dilution 1/2000) against human IFN-~, overnight at 4 °C. The complex was then labelled with a peroxidase-conjugated anti-mouse IgG (Miles Laboratories), incubated for 45 min at room temperature and detected with diaminobenzidine and hydrogen peroxide (Towbin et al., 1979) .
Affinity chromatography. The same monoclonal antibody as the one used in the electrophoretic transfer experiments was bound to activated CH-Sepharose 4B (Pharmacia). 1FN, phospho-labelled or not, diluted in the assay mixture indicated for phosphorylation (pH 7.2) was added to the affinity column and incubated for 20 h at 4 °C. Thereafter, the column was washed, the bound IFN eluted with Mcllvaine's citrate-phosphate buffer pH 2-2, and the fractions were tested for radioactivity.
RESULTS
Phosphorylation of IFN in contact with sensitive cells
To study the phosphorylation of IFN-7, we used a human transformed cell line (HeLa) and normal human embryonic fibroblasts (F7000). The cells were washed twice with the assay mixture (see Methods) and then treated for 15 min at 37 °C in the presence of 1 ml IFN-~, (3 x 106 U/ml) and 0.5 ~tM-[~,-32p]ATP. The cellular phase was solubilized with the sample buffer and then analysed by SDS-PAGE.
The results of the assay in normal fibroblasts (control, lane 1 ; IFN-treated, lane 2) and in HeLa cells (control, lane 3; IFN-treated, lane 4) are shown in Fig. 1 . It is of interest that the number of phosphorylating bands is significantly higher in the transformed HeLa cells when compared to normal fibroblasts. However, in both cases, an intense labelling was seen in the 17000 mol. wt. region and a less reactive but distinct double band in the 35000 tool. wt. area. These are generally attributed to the monomeric and dimeric forms of recombinant IFN-7 and will be proven clearly further on in the text.
Lack of phosphorylation of human IFN-c~, IFN-~ and mouse IFN
The effect of such cellular protein kinases on other IFN species of human or animal origin was compared (Fig. 2) . HeLa cells were treated by human IFN-c~ (lane 4), IFN-/~ (lane 2) and IFN-~, (lane 3) and by mouse IFN-~//~ (lane 6) in the same manner as described above. An additional control (lane 5) was performed using assay buffer supplemented with human serum albumin at the same concentration (2 mg/ml) as IFN-7. All IFNs were used at comparable concentrations based on their antiviral effect on HeLa cells (10 7 reference units in 1 ml). Mouse IFN was used at the concentration of 2 x 106 reference units/ml.
Only lane 3 corresponding to IFN-7 showed labelling in the 17000 and 35000 mol. wt. areas. It is noteworthy that cloned human IFN-~z or beta interferons at similar concentrations were also not phosphorylated (data not shown).
Release of protein kinase in the supernatant from human IFN-7-treated or untreated cells
To explore whether the enzymic activity was bound to the cell membrane, present in the cytosol or, on the contrary, released in the supernatant as known for phosvitin (K~bler et al., 1983) , the cells were treated with either I ml phosvitin (1 mg/ml) or 1 ml IFN-7 (107 units/ml) for 15 min at 37 °C. The supernatant was then removed and centrifuged and [7-32p]ATP and magnesium ions were added. The mixture was incubated for 15 min at 30 °C. The preparation was diluted 1:2 with sample buffer and analysed by SDS-PAGE.
The results obtained after autoradiography are presented in Fig. 3 . The zone corresponding to either monomeric or dimeric IFN-~ was strongly labelled by [7-32p] ATP, while with phosvitin the phosphorylated bands were found in the 43000 mol. wt. area (Fig. 3a) , in agreement with Kiibler et al. (1983) . When HeLa cells were incubated for 15 min with assay mixture and the supernatant mixed 1:2 with IFN-y, a similar pattern of phosphorylation was seen with a somewhat lower intensity (Fig. 3b) . If IFN was incubated only with [7-32p]ATP and buffer, no reaction was detected (data not shown). Thus, protein kinase was released from the ceils in the supernatant whether or not they were treated with IFN-7.
Dose-response relationship
The dose-response effect was studied by measuring phosphorylation using the supernatant from HeLa cells incubated for 15 min at 37 °C with the assay mixture or with a range of increasing concentrations of IFN-7 from l0 s to 3 × l07 as shown in Fig. 4 . To each aliquot, [7-32p] ATP was added for 15 min at 30°C.
The results show a linear dose-response relationship between the amount of IFN used and the count. This linearity is also illustrated in the insert which represents the SDS-gel electrophoresis of each subsequent IFN aliquot when the reaction was completed. 
Release of protein kinase from different cell species
It was of interest to investigate to what extent the protein kinase, released from different cell species, phosphorylated human IFN-y. For reference, phosvitin was employed. The results, summarized in Table 1 , clearly show that all the cells tested released protein kinase, even phylogenetically remote species such as fish and mosquito cells. The level of phosphorylation was, however, not parallel when comparing phosvitin and IFN-y. Furthermore, when controlled in S D S -P A G E , as already indicated previously, both IFN-y molecular species were labelled, whatever the cell type employed, while in the presence of phosvitin, a 43 000 mol. wt. band was seen (data not shown).
Phosphorylation of serine residues
The amino acid residues of IFN-~,, which bind the phosphoryl group from [v-3zp]ATP, were analysed. The major 17000 mol. wt. component eluted from S D S -P A G E was employed. The hydrolysed molecule was applied on a column containing DC6A sulphonated polystyrene resin, as described in Methods (Capony & Demaille, 1983) . As reference, phosphoserine, phosphothreonine and phosphotyrosine were used. In Fig. 5 , we show the fluorescence diagram obtained. The first important peak represents the unbound material after inoculation. The different fractions were tested for radioactivity. The only phospho-labelled peak was found at the retention time corresponding to phosphoserine, while phosphothreonine and phosphotyrosine were not radioactive. Similar results (not shown here) were obtained using thin-layer electrophoresis (Hunter & Sefton, 1980) . * Cells were incubated with assay mixture for 15 min at 37 °C. The supernatants were collected and diluted 1 : 2 with either IFN-y or phosvitin. Phosphorylation was performed as described in Methods.
"~ NT, Not tested.
Effect of phosphorylation on antiviral fimctions and binding to monoclonal antibodies
It was of interest to explore w h e t h e r or not p h o s p h o r y l a t i o n modified the biological p r o p e r t i e s a n d the a n t i g e n i c responsiveness of the r e c o m b i n a n t molecule. In six successive e x p e r i m e n t s we could not detect a n y c h a n g e in the capacity to p r o t e c t W I S H cells w h e t h e r or n o t the molecule was p h o s p h o r y l a t e d (data not shown). F u r t h e r m o r e , monospecific a n t i s e r u m n e u t r a l i z e d similarly the a n t i v i r a l effect of p h o s p h o r y l a t e d or control I F N .
T h e effect of p h o s p h o r y l a t i o n on the b i n d i n g to m o n o c l o n a l a n t i b o d i e s was studied using a W e s t e r n blot transfer, as described in M e t h o d s . As s h o w n in The only peak containing the radiolabel is that of P-serine (P-SER) (arrow). 
Anti-proliferative properties of IFN-?
[ 3H 
Lack of detectable modification of IFN-7 anti-proliferative properties after phosphorylation
It is well-known that IFN-7, like the other IFNs, inhibits Cell proliferation (Rubin & Gupta, 1980) . We have tested human amniotic WISH and lymphoblastoid Daudi cells, studying in parallel DNA synthesis and cell count, as indicated in Methods.
Both the 17000 and 35000 mol. wt. fractions of 1FN-y were incubated on cells and phosphorylated. Then the phosphorylated or unphosphorylated IFN-~ was analysed for its antiproliferative capacities. In WISH cells, the inhibition of cellular DNA synthesis was not modified by phosphorylation, as shown in Table 2 . Similarly, the IFN-induced decrease of the thymidine pool size was not altered. Daudi cells, which are completely insensitive to IFN-~, while highly responsive to IFN-a, were also unaffected by the phosphorylated or unphosphorylated IFN molecules (data not shown).
DISCUSSION
The data presented here show that recombinant IFN-v is phosphorylated in serine residues by protein kinases released from the cells. The immune electrophoretic transfer and the affinity chromatographical identification show unequivocally that the phosphorylated proteins are indeed two molecular forms of IFN-% Alpha or beta interferons incubated in parallel with the same kinase preparation are not phosphorylated. There are considerable differences in the structure of the IFNcqfl and IFN-v molecules, and this observation represents thus an additional distinction between the two IFN groups.
The dose-response relationship between the concentration of IFN-v and the amount of IFN molecules phosphorylated is linear.
It is of interest that a number of cell species even located far apart in the phylogenetic scale can release such kinase activity, phosphorylating the IFN-y. It is thus evident that this procedure is not involved in antiviral activity since such cells are unresponsive to the human IFN species. There is no information as to whether a single kinase is involved or whether different enzymes of this type are able to phosphorylate IFN-7.
It is also presently not known whether the molecule released from the cells is comparable or not to protein kinase C (Nishizuka, 1984) or the one which activates the phosvitin molecules after being released from the cells. Antigenicity and antiviral and anti-proliferative properties of IFN-v are seemingly unaffected by phosphorylation, which does not exclude, however, possible changes in other presently unknown biological functions it possesses. Besides its theoretical interest, it is noteworthy that the phosphorylation of IFN-v is easily obtained and can be applied to biological tests, including radioimmunoassays.
